Literature DB >> 21318586

Differentiation-inducing activity of hydroxycamptothecin on cancer stem-like cells derived from hepatocellular carcinoma.

Yi Zhang1, Wen-Jie Song, Fu-Qin Zhang, Wei-Hui Liu, Ke-Feng Dou.   

Abstract

BACKGROUND: Hydroxycamptothecin (HCPT) is an anti-tumor agent that can induce differentiation in human cancer cells. Recent evidence indicates that side population (SP) cells possess characteristics of stem-like cells, and may be capable of initiating tumor growth. AIMS: The present study investigated the differentiation of cancer stem-like cells derived from hepatocellular carcinoma. METHODS AND
RESULTS: Flow cytometry was used to isolated SP cells from HCC cell line (MHCC97 cells). These SP cells exhibit several stem-like cell characteristics that are distinct from the main population (MP) cells in vitro. After 3 days of induction with a low concentration of HCPT, the SP cells lost their capacity to proliferate and invade, and their tumorigenicity declined. Based on real-time quantitative RT-PCR, we also found that the expression of hepatocyte-specific markers such as α-fetoprotein, albumin, hepatocyte nuclear factor-4 and miR-122 gradually changed during the differentiation of SP cells.
CONCLUSIONS: Our data suggest that a low concentration of HCPT can induce hepatocyte-specific differentiation of cancer stem-like cells from MHCC97 cells, offering a possible therapeutic strategy for the treatment of human malignancies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21318586     DOI: 10.1007/s10620-011-1601-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  38 in total

Review 1.  Differentiation therapy.

Authors:  Alexander I Spira; Michael A Carducci
Journal:  Curr Opin Pharmacol       Date:  2003-08       Impact factor: 5.547

2.  Major achievements in hepatocellular carcinoma.

Authors:  Jordi Bruix; Josep M Llovet
Journal:  Lancet       Date:  2009-02-21       Impact factor: 79.321

Review 3.  Normal stem cells and cancer stem cells: similar and different.

Authors:  Mark Shackleton
Journal:  Semin Cancer Biol       Date:  2010-04-29       Impact factor: 15.707

Review 4.  Tumour stem cells and drug resistance.

Authors:  Michael Dean; Tito Fojo; Susan Bates
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

5.  Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.

Authors:  Lubna Patrawala; Tammy Calhoun; Robin Schneider-Broussard; Jianjun Zhou; Kent Claypool; Dean G Tang
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

6.  Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

Authors:  Stephanie Ma; Kwok-Wah Chan; Liang Hu; Terence Kin-Wah Lee; Jana Yim-Hung Wo; Irene Oi-Lin Ng; Bo-Jian Zheng; Xin-Yuan Guan
Journal:  Gastroenterology       Date:  2007-04-15       Impact factor: 22.682

Review 7.  Cancer stem cells: cell culture, markers, and targets for new therapies.

Authors:  Candace A Gilbert; Alonzo H Ross
Journal:  J Cell Biochem       Date:  2009-12-01       Impact factor: 4.429

8.  Differential regulation of hepatocyte-enriched transcription factors explains changes in albumin and transthyretin gene expression among hepatoma cells.

Authors:  R S Herbst; U Nielsch; F Sladek; E Lai; L E Babiss; J E Darnell
Journal:  New Biol       Date:  1991-03

9.  Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.

Authors:  Maria M Ho; Alvin V Ng; Stephen Lam; Jaclyn Y Hung
Journal:  Cancer Res       Date:  2007-05-15       Impact factor: 12.701

10.  MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.

Authors:  Shoumei Bai; Mohd W Nasser; Bo Wang; Shu-Hao Hsu; Jharna Datta; Huban Kutay; Arti Yadav; Gerard Nuovo; Pawan Kumar; Kalpana Ghoshal
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

View more
  6 in total

1.  Sulforaphane suppresses EMT and metastasis in human lung cancer through miR-616-5p-mediated GSK3β/β-catenin signaling pathways.

Authors:  Da-Xuan Wang; Yu-Jiao Zou; Xi-Bin Zhuang; Shu-Xing Chen; Yong Lin; Wen-Lan Li; Jun-Jin Lin; Zhi-Qiang Lin
Journal:  Acta Pharmacol Sin       Date:  2016-11-28       Impact factor: 6.150

2.  Isocorydine targets the drug-resistant cellular side population through PDCD4-related apoptosis in hepatocellular carcinoma.

Authors:  Ping Lu; Hefen Sun; Lixing Zhang; Helei Hou; Lin Zhang; Fangyu Zhao; Chao Ge; Ming Yao; Tingpu Wang; Jinjun Li
Journal:  Mol Med       Date:  2012-09-25       Impact factor: 6.354

3.  Sorting and biological characteristics analysis for side population cells in human primary hepatocellular carcinoma.

Authors:  Yegui Jiang; Hucheng Gao; Mingdong Liu; Qing Mao
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

Review 4.  Interpretation of interlocking key issues of cancer stem cells in malignant solid tumors.

Authors:  Wei-Hui Liu; Nan You; Ning Zhang; Hong-Tao Yan; Tao Wang; Zhu Huang; Hong-Bao Liu; Li-Jun Tang
Journal:  Cell Oncol (Dordr)       Date:  2012-11-22       Impact factor: 6.730

Review 5.  MicroRNAs and Chinese Medicinal Herbs: New Possibilities in Cancer Therapy.

Authors:  Ming Hong; Ning Wang; Hor Yue Tan; Sai-Wah Tsao; Yibin Feng
Journal:  Cancers (Basel)       Date:  2015-08-24       Impact factor: 6.639

6.  Differentiation-inducing therapeutic effect of Notch inhibition in reversing malignant transformation of liver normal stem cells via MET.

Authors:  Hao Luo; Wei-Hui Liu; Hong-Yin Liang; Hong-Tao Yan; Ning Lin; Dong-Yu Li; Tao Wang; Li-Jun Tang
Journal:  Oncotarget       Date:  2018-02-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.